Hongqian Guo

37PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Aug 08, 2026
A Pathology-Based Model for Postoperative Recurrence or Metastasis Prediction and Adjuvant Immunotherapy Implications of Clear-Cell Renal Cell Carcinoma: A Multicenter, Retrospective Study.

|Jun 19, 2026
Magnetic resonance imaging-targeted biopsy with index lesion ipsilateral or bilateral systematic biopsy in prostate cancer: A multicenter, paired, noninferiority, observational trial.

|Apr 08, 2026
Hierarchical Zeolitic Imidazolate Framework-8@Au Cluster Nanocarriers for In Situ Chimeric Antigen Receptor Macrophage Programming and Immunotherapy in Prostate Cancer.

Zichen Liang, Rui Wang, Yiyang Wang

|Dec 17, 2025
Patient-derived organoids based on targeted biopsy of primary prostate cancer: development, identification, and drug screening.

Jiajun Qian, Shan Peng, Jie Gao

|Nov 07, 2025
SLC6A19-mediated tryptophan uptake suppresses renal cell carcinoma metastasis via activating NAD+-dependent deacetylase SIRT1.

Ziyi Chen, Runjie Duan, Zeqing Chen

|May 08, 2025
Biomimetic Copper Nanozyme Reprograms Cold Tumor via Cuproptosis-Pyroptosis Crosstalk for Potent Renal Carcinoma Immunotherapy.

Mengtong Wu, Kangkang Zhao, Xinyue Tao

Pageof 7

Frequent Collaborators

3 joint publications

Zihan Zhao

2 joint publications

Giancarlo Marra

2 joint publications

Giorgio Calleris

2 joint publications

Alessandro Marquis